Substance Abuse, Intravenous
"Substance Abuse, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abuse, overuse, or misuse of a substance by its injection into a vein.
| Descriptor ID |
D015819
|
| MeSH Number(s) |
C25.775.793 F03.900.793
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Substance Abuse, Intravenous".
Below are MeSH descriptors whose meaning is more specific than "Substance Abuse, Intravenous".
This graph shows the total number of publications written about "Substance Abuse, Intravenous" by people in this website by year, and whether "Substance Abuse, Intravenous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 1 | 2 |
| 1993 | 1 | 0 | 1 |
| 1994 | 2 | 1 | 3 |
| 1995 | 2 | 0 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2001 | 2 | 0 | 2 |
| 2002 | 4 | 0 | 4 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 2 | 3 |
| 2015 | 0 | 2 | 2 |
| 2016 | 2 | 2 | 4 |
| 2017 | 2 | 0 | 2 |
| 2018 | 2 | 1 | 3 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Substance Abuse, Intravenous" by people in Profiles.
-
Nolte K, Drew AL, Friedmann PD, Romo E, Kinney LM, Stopka TJ. Opioid initiation and injection transition in rural northern New England: A mixed-methods approach. Drug Alcohol Depend. 2020 12 01; 217:108256.
-
Amjad W, Qureshi WT, Farooq AU. Delayed Cerebral Edema Leading to Cerebral Hernia in a Patient With Heroin Overdose. Am J Ther. 2018 Nov/Dec; 25(6):e752-e755.
-
Martin SA, Bosse J, Wilson A, Losikoff P, Chiodo L. Under one roof: identification, evaluation, and treatment of chronic hepatitis C in addiction care. Addict Sci Clin Pract. 2018 04 25; 13(1):10.
-
Poowanawittayakom N, Dutta A, Stock S, Touray S, Ellison RT, Levitz SM. Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA. Emerg Infect Dis. 2018 04; 24(4).
-
González G, Giraldo LF, DiGirolamo G, Rey CF, Correa LE, Cano AM, Romero-González M. Facing the Growing Heroin Problem in Colombia: The New Methadone-assisted Treatment Programs. Rev Colomb Psiquiatr (Engl Ed). 2019 Apr - Jun; 48(2):96-104.
-
Alameddine AK, Binnall B, Alameddine ZO. Resolution of extensive Janeway lesions. J Card Surg. 2017 May; 32(5):295.
-
Carreiro S, Wittbold K, Indic P, Fang H, Zhang J, Boyer EW. Wearable Biosensors to Detect Physiologic Change During Opioid Use. J Med Toxicol. 2016 09; 12(3):255-62.
-
Cushman PA, Liebschutz JM, Anderson BJ, Moreau MR, Stein MD. Buprenorphine Initiation and Linkage to Outpatient Buprenorphine do not Reduce Frequency of Injection Opiate Use Following Hospitalization. J Subst Abuse Treat. 2016 09; 68:68-73.
-
Loewinger G, Sharma B, Karki DK, Khatiwoda P, Kainee S, Poudel KC. Low knowledge and perceived Hepatitis C risk despite high risk behaviour among injection drug users in Kathmandu, Nepal. Int J Drug Policy. 2016 07; 33:75-82.
-
Lee JD, Friedmann PD, Kinlock TW, Nunes EV, Boney TY, Hoskinson RA, Wilson D, McDonald R, Rotrosen J, Gourevitch MN, Gordon M, Fishman M, Chen DT, Bonnie RJ, Cornish JW, Murphy SM, O'Brien CP. Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders. N Engl J Med. 2016 Mar 31; 374(13):1232-42.